openPR Logo
Press release

Global EYLEA Drug Market Current Analysis, Top Business Strategy, Forcast 2023-2030

01-31-2024 02:34 PM CET | Business, Economy, Finances, Banking & Insurance

Press release from: CoherentMI

Global EYLEA Drug Market

Global EYLEA Drug Market

Global EYLEA Drug Market size is expected to reach US$ 14.30 Bn by 2030, from US$ 8.79 Bn in 2023, exhibiting a compound annual growth rate (CAGR) of 7.2% during the forecast period 2023-2030. EYLEA, also known as aflibercept, is a vascular endothelial growth factor inhibitor protein used for the treatment of wet age-related macular degeneration and macular edema following retinal vein occlusion. EYLEA helps vision by inhibiting VEGF.

The Global EYLEA Drug Market is driven by the increasing prevalence of eye diseases such as age-related macular degeneration (AMD), diabetic macular edema (DME), diabetic retinopathy (DR) and other retinal diseases. As per the Bright Focus Foundation, globally more than 196 million people are affected by AMD. Similarly, Diabetes Control and Complications Trial Research Group estimates around 7.7 million people suffer from diabetic retinopathy worldwide. These diseases require anti-VEGF therapies such as EYLEA, driving the market growth during the forecast period. Additionally, increasing healthcare expenditure and rising awareness regarding eye diseases are further contributing to the market growth.

One major market opportunity for companies in the EYLEA drug field involves further expanding diagnosis and treatment rates for eye diseases like AMD. These conditions remain under-diagnosed and under-treated around the world. For example, it is estimated that only about 20-30% of AMD patients receive treatment. This leaves a large gap for increased screening that could detect more cases appropriate for anti-VEGF drugs. Educating eye care professionals and the public about the warning signs of eye diseases is crucial to catching more cases early before substantial vision is lost. The availability of effective medicines then motivates diagnosis, representing an opportunity to increase the potential patient pool for EYLEA.

Explorer more information on this topic, Please visit @ https://www.coherentmi.com/industry-reports/global-eylea-drug-market

Top Key Players:

Bayer
Regeneron Pharmaceuticals
Coherus BioSciences, Inc.
Klinge Biopharma

Segmentation Analysis:

By Type -

Wet Age-Related Macular Degeneration (Wet AMD)
Diabetic Retinopathy (DR)
Diabetic Macular Edema (DME)
Retinal Vein Occlusion (RVO)
Myopic Choroidal Neovascularization (mCNV)
Others

By Application -

Hospitals
Ophthalmic Clinics
Others

For More Insights: https://www.coherentmi.com/industry-reports/global-eylea-drug-market

Reasons to Purchase this Report:

◉ Regional analysis provides insights into the factors influencing the market in each location, including product/service consumption.
◉ The report identifies global opportunities and risks faced by manufacturers of Global Global EYLEA Drug Market Market.
◉ The study highlights areas and sectors with high potential for expansion.
◉ Detailed coverage of a competitive market, including firm market rankings, new product introductions, joint ventures, corporate growth, and acquisitions.
◉ In-depth analysis of major market players, including company overviews, corporate insights, product benchmarking, and SWOT analysis.
◉ Industry market overview for the present and future, considering recent advancements, growth potential, motivating factors, challenges, and geographical limits in developed regions.

Frequently Asked Questions (FAQs):

➟ What is the main driving factor for the growth of the Global Global EYLEA Drug Market Market?
➟ What are the restraining factors of the market?
➟ Who are the key market players?
➟ Which region holds the biggest market share?
➟ What are the recent trends of the Global Global EYLEA Drug Market Market?

Buy This Premium Report@ https://www.coherentmi.com/industry-reports/global-eylea-drug-market/buyNow

Don't miss this chance to equip yourself with the knowledge you need to drive growth and stay ahead in the market. Act now and unlock the power of data-driven decision-making with our premium Global Global EYLEA Drug Market Market research report.

Global EYLEA Drug Market Report Snapshots
Global EYLEA Drug Market Size
Global EYLEA Drug Market Share
Global EYLEA Drug Market Trends
Global EYLEA Drug Companies

Contact Us

CoherentMI
U.S.: +1-206-701-6702
U.K: +44-020-8133-4027
JAPAN: +81-50-5539-1737
INDIA: +91-848-285-0837
sales@coherentmi.com

About Us:

At CoherentMI, we are a leading global market intelligence company dedicated to providing comprehensive insights, analysis, and strategic solutions to empower businesses and organizations worldwide. Moreover, CoherentMI is a subsidiary of Coherent Market Insights Pvt Ltd., which is a market intelligence and consulting organization that helps businesses in critical business decisions. With our cutting-edge technology and experienced team of industry experts, we deliver actionable intelligence that helps our clients make informed decisions and stay ahead in today's rapidly changing business landscape.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Global EYLEA Drug Market Current Analysis, Top Business Strategy, Forcast 2023-2030 here

News-ID: 3368215 • Views:

More Releases from CoherentMI

How the Autosomal Dominant Polycystic Kidney Disease Market Will Evolve by 2032 - Growth, Segments, and Revenue Trends| Otsuka Pharmaceutical, Reata Pharmaceuticals
How the Autosomal Dominant Polycystic Kidney Disease Market Will Evolve by 2032 …
The latest report on the "Autosomal Dominant Polycystic Kidney Disease Market" by CoherentMI delivers a comprehensive and detailed evaluation of global industry dynamics, uncovering the core trends that shape the competitive landscape. By analyzing key growth drivers, market constraints, emerging opportunities, and sector challenges, the study offers an extensive understanding of the market's behavior. This report is based on rigorously validated research methodologies, ensuring data precision and credibility. It explores
What's Driving the Future of the Ocular Hypertension Market? Insights, Forecasts, and Emerging Frontiers |Nicox, Qlaris Bio, TheratOcular Biotek Co.Ltd.
What's Driving the Future of the Ocular Hypertension Market? Insights, Forecasts …
The latest report on the "Ocular Hypertension Market" by CoherentMI delivers a comprehensive and detailed evaluation of global industry dynamics, uncovering the core trends that shape the competitive landscape. By analyzing key growth drivers, market constraints, emerging opportunities, and sector challenges, the study offers an extensive understanding of the market's behavior. This report is based on rigorously validated research methodologies, ensuring data precision and credibility. It explores critical factors such
From Now to 2032: Unpacking the Epithelioid Sarcoma Market's Evolution, Opportunities, and Key Trends |Epizyme, Eli Lilly and Company, Pfizer, Merck Sharp & Dohme
From Now to 2032: Unpacking the Epithelioid Sarcoma Market's Evolution, Opportun …
The most recent in-depth analysis from CoherentMI offers a comprehensive global perspective on the evolving Epithelioid Sarcoma Market, equipping industry stakeholders with data-backed insights into shifting market dynamics, innovation cycles, and emerging business models. This report serves as a trusted roadmap for organizations navigating a landscape shaped by increasing competition, technological disruption, and fluctuating demand across geographies. From strategic positioning to investment trends, the study provides clarity on both micro
A Look Into the Future: Clear Cell Ovarian Cancer Market Set for Disruption and Growth Through 2032 |Genentech, GlaxoSmithKline, Clovis Oncology, AstraZeneca
A Look Into the Future: Clear Cell Ovarian Cancer Market Set for Disruption and …
The latest report on the "Clear Cell Ovarian Cancer Market" by CoherentMI delivers a comprehensive and detailed evaluation of global industry dynamics, uncovering the core trends that shape the competitive landscape. By analyzing key growth drivers, market constraints, emerging opportunities, and sector challenges, the study offers an extensive understanding of the market's behavior. This report is based on rigorously validated research methodologies, ensuring data precision and credibility. It explores critical

All 5 Releases


More Releases for EYLEA

Eylea Market Thrives On Addressing The Rise In Ocular Diseases: Transformative F …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts. What Will the Eylea Industry Market Size Be by 2025? There has been a robust expansion in the eylea market size over the past few years. The market, which will rise from $9.94 billion in 2024, is projected to hit $10.51 billion in 2025, representing a compound annual growth
Eylea Market Emerging Trends and Growth Prospects 2034
Eylea market Size, Status, and Forecast for the 2025-2034. In-depth research has been compiled to provide the most up-to-date information on key aspects of the worldwide market. This research report covers major aspects of the Eylea Market including drivers, restraints, historical and current trends, regulatory scenarios, and technological advancements. It provides the industry overview with growth analysis and historical & futuristic cost, revenue, demand and supply data (as applicable). The
Eylea Market Outlook 2025-2034: Key Trends, Growth Drivers, and Market Share
What market dynamics are playing a key role in accelerating the growth of the eylea market? The Eylea market is anticipated to expand with the escalating incidence of eye ailments. These ocular maladies interfere with the precise functioning of the eye and can negatively influence visual clarity. Often, these issues remain symptomless until reaching a critical stage. Eylea is beneficial in addressing conditions like wet age-related macular degeneration (AMD) and glaucoma,
Global EYLEA Drug Market Imapct of AI and Automation
EYLEA Drug Market Impact of AI and Automation In 2022, the EYLEA drug market was valued at approximately $7.3 billion. The market is projected to experience a compound annual growth rate (CAGR) of 7.5% from 2022 to 2030. This growth trajectory highlights a robust expansion in the treatment of retinal diseases, reflecting both increasing patient populations and advancements in medical technology. The ultimate drivers of this growth include ongoing research and
Eylea Market Growth, Trends & Competitive Analysis 2024-2033
The Business Research Company recently released a comprehensive report on the Global Eylea Market Size and Trends Analysis with Forecast 2024-2033. This latest market research report offers a wealth of valuable insights and data, including global market size, regional shares, and competitor market share. Additionally, it covers current trends, future opportunities, and essential data for success in the industry. According to The Business Research Company's, The eylea market size has
Eylea Market 2024 Report By Key Companies, Regional Analysis And Forecast 2033
The new report published by The Business Research Company, titled "Eylea Global Market Report 2024 - Market Size, Trends, And Global Forecast 2024-2033", delivers an in-depth analysis of the leading size and forecasts, investment opportunities, winning strategies, market drivers and trends, competitive landscape, and evolving market trends. As per the report, the eylea market size has grown strongly in recent years. It will grow from $7.8 billion in 2023 to